News Medical4h
Groundbreaking advances in tuberculosis vaccine development and therapies
Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.
Vaxart secures $105.9 million more for COVID-19 pill vaccine trial
Vaxart, Inc. (NASDAQ:VXRT), a biotechnology company specializing in the development of oral recombinant vaccines with a market capitalization of approximately $159 million, announced on Monday an ...
cidrap.umn11h
Financial incentives did not increase COVID vaccine uptake, study finds
Among adults in Ravensburg, Germany, financial incentives for COVID-19 vaccination did not result in significant changes to vaccine uptake and may have inadvertently lowered community vaccination ...
Dr. Fauci's $170,000 planned museum exhibit canceled by DOGE days after security ripped away
Dr. Anthony Fauci is no longer getting the honor of his own exhibit at the National Institutes of Health museum, thanks to Elon Musk's DOGE.
The National Law Review13h
Vax On: Fourth Circuit Reinstates Plaintiff’s Religious Bias Suit in COVID Vaccine Mandate Case
On January 7, the United States Court of Appeals for the Fourth Circuit reversed and remanded a district court’s dismissal of ...
cidrap.umn14h
Data: Despite high risk of poor outcomes, only 1% of pregnant COVID patients given antiviral
The rate of antiviral prescriptions was 67% lower in pregnant than in nonpregnant women, including those with one or more high-risk underlying conditions.
New research uncovers hidden rules of immune response, opening doors for better vaccines and immunotherapies
Scientists at the Institute for Systems Biology (ISB) have uncovered key insights into how T cells—the body's frontline ...